New criteria could identify more patients in early stages of disease, promote better care and stimulate research to slow and prevent COPD NATIONAL JEWISH HEALTH DENVER – November 12, 2019 – Researchers at National Jewish Health and dozens of leading institutions around the nation have proposed new criteria for diagnosing chronic obstructive pulmonary disease (COPD),...
Tag: <span>chronic obstructive pulmonary disease (COPD)</span>
Post
Beta-blocker trial does not reduce risks for COPD patients
by Adam Pope, University of Alabama at Birmingham New research from scientists at the University of Alabama at Birmingham published in the New England Journal of Medicine has found that beta-blockers used in a clinical trial for patients with chronic obstructive pulmonary disease do not reduce the risk of flare-ups of the disease, also called...
Post
New risk scores help physicians provide better care for high-risk pulmonary patients, study finds
INTERMOUNTAIN MEDICAL CENTER A new laboratory-based method of estimating outcomes for patients with a severe pulmonary disorder that has no cure can help physicians better provide proper care, referrals, and services for patients at the end of life, according to a new study of more than 17,000 patients from Intermountain Healthcare. The Laboratory-based Intermountain Validated Exacerbation (LIVE) score is a prediction model that predicts all-cause mortality, morbidity, and hospitalization rates for patients with chronic obstructive pulmonary disease (COPD),...
Post
Activated PMN exosomes are pathogenic entities that cause destruction in the COPD lung
University of Alabama at Birmingham researchers have found a novel, previously unreported pathogenic entity that is a fundamental link between chronic inflammation and tissue destruction in the lungs of patients with chronic obstructive pulmonary disease, or COPD. COPD is the fourth-leading cause of death in the world. Credit: CC0 Public Domain This pathogenic entity—exosomes from...
Post
Flu shot crucial for those with COPD
(HealthDay)—If you suffer from chronic obstructive pulmonary disease (COPD), a flu shot can be a lifesaver. But many of the millions with the lung condition don’t get it, researchers report. COPD causes inflammation in the lungs and it can flare up when triggered by the flu, making the infection worse, explained lead researcher Dr. Sunita Mulpuru. She is an associate...
Post
Self-management program for patients with COPD boosts quality of life, cuts re-hospitalization
Johns Hopkins Medicine researchers report that a program designed to enhance self-care and lead to more seamless management of chronic obstructive pulmonary disease (COPD) in adults successfully reduced rates of emergency room visits and hospitalization, and the burdensome symptoms and limitations caused by the condition. Micrograph showing emphysema (left – large empty spaces) and lung...
Post
We’re doing drug trials wrong – here’s how to fix it
By the age of 65, at least half of us will suffer from two or more long-term diseases. And the chance of having multi-morbidity, as it is known, increases with age. Only 9% of people with coronary heart disease have no other condition. The other 91% have various combinations of hypertension (high blood pressure), heart...
Post
Benzodiazepines in patients with COPD and PTSD may increase suicide risk
AMERICAN THORACIC SOCIETY Oct. 12, 2018–Long-term use of benzodiazepine medications in patients with chronic obstructive pulmonary disease, or COPD, as well as posttraumatic stress disorder (PTSD) may lead to increased suicide risk, according to a study published online in the Annals of the American Thoracic Society. IMAGE: COMORBID COPD AND PTSD PATIENTS TREATED FOR LONG PERIOD WITH BENZOS AT INCREASED SUICIDE RISK. CREDIT: ATS In “Risks of Benzodiazepines in Chronic Obstructive Pulmonary...
Post
Autoimmunity plays role in development of COPD, study finds
Autoimmunity plays a role in the development of chronic obstructive pulmonary disease (COPD), according to a study led by Georgia State University and Vanderbilt University Medical Center that analyzed human genome information stored in Vanderbilt’s DNA biobank. Micrograph showing emphysema (left – large empty spaces) and lung tissue with relative preservation of the alveoli (right)....
Post
Study: Process used to select lung transplant patients may need to be changed
Baltimore, Md., Nov. 14, 2017 – With a limited number of lungs available, deciding who gets a transplant can be a matter of life or death. New research from the University of Maryland School of Medicine (UMSOM) suggests that the system for choosing transplant recipients in chronic obstructive pulmonary disease (COPD) may underestimate how long...
- 1
- 2